| Univariate | Multivariable | |||
|---|---|---|---|---|
| OR (95% CI) | p‐Value | OR (95% CI) | p‐Value | |
| Age, (years) | 1.02 (1.00–1.03) | 0.0109 | 1.01 (0.99–1.03) | 0.4146 |
| Male, n (%) | 0.58 (0.42–0.79) | <0.0001 | 0.75 (0.47–1.20) | 0.2288 |
| Paroxymal Atrial Fibrillation, n (%) | 0.88 (0.64–1.21) | 0.4245 | ||
| Comorbidities, n (%) | ||||
| Heart failure | 1.10 (0.71–1.69) | 0.6803 | ||
| Hypertension | 1.08 (0.79–1.47) | 0.6313 | ||
| Diabetes mellitus | 1.07 (0.71–1.62) | 0.7452 | ||
| Stroke | 0.91 (0.56–1.48) | 0.7053 | ||
| CHA2DS2‐VASc score | 1.06 (0.97–1.17) | 0.2032 | ||
| Echocardiography | ||||
| LA dimension, mm | 1.00 (0.97–1.02) | 0.7055 | ||
| LA volume index, ml/m2 | 1.02 (1.01–1.03) | 0.0025 | ||
| LV ejection fraction, % | 1.00 (0.98–1.02) | 0.6923 | ||
| EEm | 1.03 (0.99–1.06) | 0.1505 | ||
| LV mass index, g/m2 | 1.00 (1.00–1.01) | 0.4001 | ||
| Pericardial fat volumes | 1.00 (0.99–1.00) | 0.0438 | 1.00 (0.99–1.00) | 0.1796 |
| LA voltage | 0.70 (0.55–0.88) | 0.0027 | 0.68 (0.47–0.98) | 0.0399 |
| LA pressure | ||||
| Peak pressure, AF | 1.00 (0.98–1.02) | 0.8003 | ||
| Mean pressure, AF | 0.99 (0.96–1.02) | 0.5352 | ||
| Peak pressure, SR | 1.01 (1.00–1.03) | 0.1582 | ||
| Mean pressure, SR | 1.01 (0.98–1.03) | 0.5014 | ||
| RVSP | 1.01 (0.99–1.03) | 0.4605 | ||
| HRV (post‐AFCA 3 mo) | ||||
| LF | 1.01 (1.00–1.02) | 0.1340 | ||
| HF | 1.03 (1.00–1.05) | 0.0211 | 1.02 (0.99–1.04) | 0.1914 |
| LF/HF | 0.91 (0.62–1.35) | 0.6512 | ||
ExPVT, extrapulmonary vein trigger; LA, left atrium; LV, left ventricle; Eem, ratio of the early diastolic mitral inflow velocity (E) to the early diastolic mitral annular velocity (Em); AF, atrial fibrillation; RVSP, right ventricle systolic pressure; HRV, heart rate variabilities; LF, low‐frequency component; HF, high‐frequency component.